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1. INTRODUCTION
jj Because of the higher risk for respiratory and liver complications in patients with CF,  specific 
recommendations for vaccination include the administration of influenza,  pneumococcal, 
varicella, HAV and HBV vaccines. 
jj Otherwise, vaccination in patients with CF should follow the usual vaccination schedule of 
the general population.
jj Live attenuated vaccines are not contraindicated but must be administered before lung 
transplantation.
 Table 1: Vaccines and vaccination schedules for adult CF patients*a,b
Vaccine Vaccination schedule Comment
Baseline 
vaccination
Influenza (inactivated) 1 dose yearly   
(tetravalent if possible)
Vaccinate also relatives 
and households with a 
single dose.
Pertussis (Tdap) 1 dose at the  
age of 25-29
Tdap is a combination 
vaccine for tetanus and 
diphtheria. Although in the 
current guidelines it is not  
recommended for the  
general population, CF  
patients may benefit from 
the use of Tdap (instead  
of Td) every 10-20 years.
Vaccinate relatives and 
households with a single 
dose.
Tetanus / diphtheria (Td) 1 dose every 10-20 years
Varicella*c 2 doses 4 weeks apart In seronegative patients
Hepatitis B 3-dose series at 0,1,6 
months
Control anti-HBs at 4 
weeks after last dose.
Accelerated schedules 
with 4 doses may be used.
Human Papillomavirus 3-dose series For females and males 
9-26 years-old
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Pneumococcal 
Conjugated Vaccine-13*b
1 dose Currently, no recommen-
dation regarding boosting 
doses can be made.
Wait >12 months if pneu-
mococcal polysaccharide 
vaccine-23 has been 
administered
MMR*c 1–2 doses In adults, 1 dose followed 
by serological control and 
a booster administration if 
no seroconversion
Travel- 
related 
vaccination
Hepatitis A 2 doses 6-12 months  
apart
Administer intramuscular 
pooled immunoglobulins 
in case of inadequate time 
from vaccination to travel 
Polio 1 dose
Yellow fever 1 dose
Japanese encephalitis 2 doses (0-28 days)
Rabies Pre-exposure: 4 doses 
Post-exposure: 2-4 doses
Vaccination schedule 
post-exposure to rabies 
depends on previous 
pre-exposure vaccination
Typhoid fever 
(polysaccharide)
1 dose
Typhoid fever (oral) 2 doses at days 1, 3 and 5
*a Vaccination status should be reviewed during the annual assessment. Other specific situations for vaccination status 
review include parenthood and lung transplantation (before listing and while waiting on list).
*b At the time of writing, all vaccines are reimbursed by the basic health insurance in the exception of the pneumococcal 
conjugated vaccine-13 (Prevenar®).
*c MMR and varicella are live vaccines: when there is an indication to administer any of those vaccines to a patient  
waiting on the lung transplant list, administer them as early as possible (e.g. at patient assessment for listing) to allow 
a sufficient time period between the vaccination and the transplant (ideally at least 4 weeks). If there is an urgent 
transplant occurring before this recommended period, antivirals for varicella can be given but no antivirals are available 
for MMR.
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